Shareholders Equity: The sum of preferred and common equity items.
Clearmind Medicine Inc. (CMND) had Shareholders Equity of $11.49M for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$1.57M |
|
$-1.57M |
|
$-0.47M |
|
$-2.04M |
|
$-2.04M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-1.57M |
|
$-1.57M |
|
0.30M |
|
0.30M |
|
$-6.78 |
|
$-6.78 |
|
| Balance Sheet Financials | |
$14.32M |
|
-- |
|
$0.20M |
|
$14.52M |
|
$2.99M |
|
$0.04M |
|
$0.04M |
|
$3.03M |
|
$11.49M |
|
$11.40M |
|
|
Shareholders Equity |
$11.49M |
1.02M |
|
| Cash Flow Statement Financials | |
$-3.85M |
|
$-0.65M |
|
$12.00M |
|
$3.92M |
|
$11.42M |
|
$7.49M |
|
$1.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.82% |
|
-17.96% |
|
-14.10% |
|
-17.75% |
|
$11.28 |
|
$-12.76 |
|
$-12.76 |
|